Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bioequivalence studies: Biowaivers

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Blinding

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A p53-ΔNp73 signaling axis drives selective motor neuron degeneration in spinal muscular atrophy.

bioRxiv : the preprint server for biology·2026

Same author

A standardized framework resolves ambiguity in motor neuron loss across neurodegenerative diseases.

bioRxiv : the preprint server for biology·2026

Same author

Biliopancreatic limb obstruction secondary to 9 cm gallstone nearly two decades following open Roux-en-Y gastric bypass and cholecystectomy: a rare and challenging case.

Journal of surgical case reports·2025

Same author

Cerebellar pathology contributes to neurodevelopmental deficits in spinal muscular atrophy.

Brain : a journal of neurology·2025

Same author

Proprioceptive synaptic dysfunction is a key feature in mice and humans with spinal muscular atrophy.

Brain : a journal of neurology·2025

Same author

Catecholaminergic dysfunction drives postural and locomotor deficits in a mouse model of spinal muscular atrophy.

Cell reports·2025

Same journal

RNU4ATAC-opathy: Clinical, molecular and transcriptomic insights from a large cohort.

Genetics in medicine : official journal of the American College of Medical Genetics·2026

Same journal

Expanding the clinical spectrum of RNU4ATAC-opathies: more frequent and diverse than assumed.

Genetics in medicine : official journal of the American College of Medical Genetics·2026

Same journal

Delineating the clinical and molecular spectrum of the neurodevelopmental disorder associated with SET.

Genetics in medicine : official journal of the American College of Medical Genetics·2026

Same journal

KMT2A and KMT2B episignatures address diagnostic challenges associated with rare neurodevelopmental disorders.

Genetics in medicine : official journal of the American College of Medical Genetics·2026

Same journal

Beyond Mistrust: Diverse Biobanking Preferences Among Parents and Adolescents with Sickle Cell Disease.

Genetics in medicine : official journal of the American College of Medical Genetics·2026

Same journal

Correspondence on "Optical mapping in Black genomes: Distinct LCR22 structures and 22q11.2 deletion syndrome mechanisms" by Pastor et al.

Genetics in medicine : official journal of the American College of Medical Genetics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 15, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Interactive multimedia consent for biobanking: a randomized trial.

Christian M Simon^1,2, David W Klein³, Helen A Schartz³

¹Program in Bioethics and Humanities, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.

Genetics in Medicine : Official Journal of the American College of Medical Genetics

|April 4, 2015

Summary

This summary is machine-generated.

Interactive multimedia and enhanced interactivity independently improved understanding of biobank informed consent. Interactivity also boosted confidence, though both methods required more time than standard face-to-face consent.

More Related Videos

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses

Published on: September 11, 2023

Working with Human Tissues for Translational Cancer Research

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

Related Experiment Videos

Last Updated: Apr 15, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses

Published on: September 11, 2023

Working with Human Tissues for Translational Cancer Research

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

Area of Science:

Biobanking and participant consent
Health informatics
Human-computer interaction

Background:

Informed consent is crucial for biobank research.
Traditional face-to-face (F2F) consent processes may not optimize participant understanding.
The effectiveness of interactive multimedia in improving biobank consent is understudied.

Purpose of the Study:

To evaluate the distinct impacts of interactivity and multimedia on participant understanding and confidence in biobank informed consent.
To compare interactive multimedia consent processes with standard F2F consent.

Main Methods:

A 2x2 experimental design compared face-to-face (F2F) versus multimedia and standard versus enhanced interactivity.
200 patients were randomly assigned to different consent conditions.
All participants received the same core information from the biobank's nine-page consent document.

Main Results:

Both enhanced interactivity and multimedia independently improved participants' understanding of biobank consent information.
Enhanced interactivity significantly increased participant confidence in their understanding, while multimedia did not.
Multimedia consent processes required more time (18.2 min) compared to F2F (12.6 min).

Conclusions:

Interactivity and multimedia are effective tools for enhancing understanding and confidence in biobank informed consent.
Researchers should differentiate between multimedia and interactivity when designing electronic consent systems.
While beneficial, these enhanced methods necessitate a greater time commitment from participants.